About Us

About Us

MyMD Pharmaceuticals, Inc. is an early-stage development company pursuing the  discovery of mechanisms of diseases that affect an aging population, followed by implementation of treatments to prevent or cure them.

Our working hypothesis is that an excessive accumulation of reactive oxygen species (ROS) within the cell contributes to the development of different types of diseases that are known to increase with aging, such as autoimmune diseases and cancers.

Aided by advances in the understanding of cell biology and drug design, we focus on designing therapies that target the root of the disease, at the intracellular level. In particular, we aim to achieve a significant improvement over therapies that are more toxic or affect only the symptoms of the disease, rather than its causes.